{"id":1433,"date":"2017-06-29T15:13:49","date_gmt":"2017-06-29T15:13:49","guid":{"rendered":"https:\/\/beta.oxforddrugdesign.com\/index.php\/2023\/10\/25\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/"},"modified":"2023-10-26T17:20:59","modified_gmt":"2023-10-26T17:20:59","slug":"james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/","title":{"rendered":"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board"},"content":{"rendered":"<p>Oxford Drug Design is pleased to announce the appointment of James B. Kahn, M.D. FIDSA, to the company\u2019s Scientific Advisory Board.<\/p>\n<p>\nDr. Kahn has deep and extensive knowledge of antibacterial drug development. He is Board-certified in both I.M. and I.D. After 18 years in the solo private practice of I.D. Medicine, James was recruited by Johnson &amp; Johnson&#8217;s Ortho-McNeil Pharmaceutical to be the first Director of their new I.D. Franchise. In addition to running numerous clinical trials for the antimicrobial FLOXIN, he also took over the clinical development of LEVAQUIN and was responsible for the sNDAs that led to 8 new FDA-approved indications. He proposed and then developed the higher-dose, shorter-course approach to accelerate pathogen eradication and reduce anti-bacterial exposure.<\/p>\n<p>\nJames is the founder and principal of JBK Strategic Consultations, LLC, a small firm providing Infectious Disease expertise to the Pharmaceutical, Venture Capital, and Medico-legal communities. He attends numerous national and international I.D. meetings and maintains close personal and professional contacts with many US and global opinion leaders.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oxford Drug Design is pleased to announce the appointment of James B. Kahn, M.D. FIDSA, to the company\u2019s Scientific Advisory Board. Dr. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1434,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1433","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board - Oxford Drug Design<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board - Oxford Drug Design\" \/>\n<meta property=\"og:description\" content=\"Oxford Drug Design is pleased to announce the appointment of James B. Kahn, M.D. FIDSA, to the company\u2019s Scientific Advisory Board. Dr. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxford Drug Design\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-29T15:13:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-26T17:20:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OxDrugDes\" \/>\n<meta name=\"twitter:site\" content=\"@OxDrugDes\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\/\/oxforddrugdesign.com\/#\/schema\/person\/154e6dcd687e7b710f1e7f6c42198629\"},\"headline\":\"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board\",\"datePublished\":\"2017-06-29T15:13:49+00:00\",\"dateModified\":\"2023-10-26T17:20:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/\"},\"wordCount\":187,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/\",\"url\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/\",\"name\":\"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board - Oxford Drug Design\",\"isPartOf\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png\",\"datePublished\":\"2017-06-29T15:13:49+00:00\",\"dateModified\":\"2023-10-26T17:20:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage\",\"url\":\"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png\",\"contentUrl\":\"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png\",\"width\":300,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/oxforddrugdesign.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oxforddrugdesign.com\/#website\",\"url\":\"https:\/\/oxforddrugdesign.com\/\",\"name\":\"Oxford Drug Design\",\"description\":\"A new leader in AI-based drug discovery\",\"publisher\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oxforddrugdesign.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oxforddrugdesign.com\/#organization\",\"name\":\"Oxford Drug Design\",\"url\":\"https:\/\/oxforddrugdesign.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oxforddrugdesign.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/odd-logo-tall.jpeg\",\"contentUrl\":\"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/odd-logo-tall.jpeg\",\"width\":200,\"height\":200,\"caption\":\"Oxford Drug Design\"},\"image\":{\"@id\":\"https:\/\/oxforddrugdesign.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/OxDrugDes\",\"https:\/\/www.linkedin.com\/company\/oxforddrugdesign?originalSubdomain=uk\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/oxforddrugdesign.com\/#\/schema\/person\/154e6dcd687e7b710f1e7f6c42198629\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oxforddrugdesign.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9b23a1808ff48b9d706f9ff8d1f792e73de73c6c8447df02db56b9ba6ae6d54c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9b23a1808ff48b9d706f9ff8d1f792e73de73c6c8447df02db56b9ba6ae6d54c?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"sameAs\":[\"https:\/\/beta.oxforddrugdesign.com\"],\"url\":\"https:\/\/oxforddrugdesign.com\/index.php\/author\/simonsaunders\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board - Oxford Drug Design","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board - Oxford Drug Design","og_description":"Oxford Drug Design is pleased to announce the appointment of James B. Kahn, M.D. FIDSA, to the company\u2019s Scientific Advisory Board. Dr. [&hellip;]","og_url":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/","og_site_name":"Oxford Drug Design","article_published_time":"2017-06-29T15:13:49+00:00","article_modified_time":"2023-10-26T17:20:59+00:00","og_image":[{"width":300,"height":300,"url":"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png","type":"image\/png"}],"author":"Admin","twitter_card":"summary_large_image","twitter_creator":"@OxDrugDes","twitter_site":"@OxDrugDes","twitter_misc":{"Written by":"Admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#article","isPartOf":{"@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/"},"author":{"name":"Admin","@id":"https:\/\/oxforddrugdesign.com\/#\/schema\/person\/154e6dcd687e7b710f1e7f6c42198629"},"headline":"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board","datePublished":"2017-06-29T15:13:49+00:00","dateModified":"2023-10-26T17:20:59+00:00","mainEntityOfPage":{"@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/"},"wordCount":187,"commentCount":0,"publisher":{"@id":"https:\/\/oxforddrugdesign.com\/#organization"},"image":{"@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/","url":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/","name":"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board - Oxford Drug Design","isPartOf":{"@id":"https:\/\/oxforddrugdesign.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png","datePublished":"2017-06-29T15:13:49+00:00","dateModified":"2023-10-26T17:20:59+00:00","breadcrumb":{"@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#primaryimage","url":"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png","contentUrl":"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/jameskahn-ed_opt-removebg-preview-e1620211867731.png","width":300,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/oxforddrugdesign.com\/index.php\/2017\/06\/29\/james-b-kahn-m-d-fidsa-joins-the-oxford-drug-design-scientific-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/oxforddrugdesign.com\/"},{"@type":"ListItem","position":2,"name":"James B. Kahn, M.D. FIDSA, joins the Oxford Drug Design Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/oxforddrugdesign.com\/#website","url":"https:\/\/oxforddrugdesign.com\/","name":"Oxford Drug Design","description":"A new leader in AI-based drug discovery","publisher":{"@id":"https:\/\/oxforddrugdesign.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oxforddrugdesign.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/oxforddrugdesign.com\/#organization","name":"Oxford Drug Design","url":"https:\/\/oxforddrugdesign.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oxforddrugdesign.com\/#\/schema\/logo\/image\/","url":"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/odd-logo-tall.jpeg","contentUrl":"https:\/\/oxforddrugdesign.com\/wp-content\/uploads\/2023\/10\/odd-logo-tall.jpeg","width":200,"height":200,"caption":"Oxford Drug Design"},"image":{"@id":"https:\/\/oxforddrugdesign.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/OxDrugDes","https:\/\/www.linkedin.com\/company\/oxforddrugdesign?originalSubdomain=uk"]},{"@type":"Person","@id":"https:\/\/oxforddrugdesign.com\/#\/schema\/person\/154e6dcd687e7b710f1e7f6c42198629","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oxforddrugdesign.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9b23a1808ff48b9d706f9ff8d1f792e73de73c6c8447df02db56b9ba6ae6d54c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9b23a1808ff48b9d706f9ff8d1f792e73de73c6c8447df02db56b9ba6ae6d54c?s=96&d=mm&r=g","caption":"Admin"},"sameAs":["https:\/\/beta.oxforddrugdesign.com"],"url":"https:\/\/oxforddrugdesign.com\/index.php\/author\/simonsaunders\/"}]}},"_links":{"self":[{"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/posts\/1433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/comments?post=1433"}],"version-history":[{"count":1,"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/posts\/1433\/revisions"}],"predecessor-version":[{"id":1764,"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/posts\/1433\/revisions\/1764"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/media\/1434"}],"wp:attachment":[{"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/media?parent=1433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/categories?post=1433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oxforddrugdesign.com\/index.php\/wp-json\/wp\/v2\/tags?post=1433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}